TTrialPathMatch Me to Trials
← Back to study

Eligibility check

Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis

Step 1 of 5

Where are you located?

We confirm your state so we only show studies you can actually reach.

Your answers help match you to studies and connect you with the research team. They're handled per our Privacy Policy.